We identified a novel small molecule SETDB1 inhibitor and validated its neuroprotective effect on in vitro HD cell (HTdhQ111/Q111) line and in vivo HD transgenic (YAC128) mouse model. The gene discussed is SETDB1; the disease is Huntington disease.